RDY
Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email: mail@drreddys.com www.drreddys.com
Friday, November 16, 2018 BiopharmaWatch Research 1 min read Key Takeaway: Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email: mail@drreddys.com www.drreddys.com
Corporate Relationship Department National Stock Exchang
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+8%
120-day peak, hindsight
Typical move
1.3%
average across 4 past catalysts
Lead asset
DFD06
Phase 3 · Psoriasis
Full Press Release Details
| | Dr. Reddy's Laboratories Ltd. |
| 8-2-337, Road No. 3, Banjara Hills, |
| Hyderabad - 500 034, Telangana, |
| India. |
| CIN : L85195TG1984PLC004507 |
| Tel : +91 40 4900 2900 |
| Fax : +91 40 4900 2999 |
| Email: mail@drreddys.com |
| www.drreddys.com |
| Corporate Relationship Department | | National Stock Exchange of India Ltd. |
| BSE Limited | | "Exchange Plaza" |
| Dalal Street, Fort | | Bandra-Kurla Complex, Bandra (East), |
| Mumbai - 400 001 | | Mumbai - 400 051 |
| Fax Nos.: | 022-22723121 / 22723719 / | | Fax Nos.: | 022-26598120/ 26598237/ |
| | 22722037 / 22722039 | | | 26598238 |
This is to inform you that the audit of
our Formulations Srikakulum Plant (SEZ) Unit II, Andhra Pradesh by the US FDA, has been completed today with zero observations.
This is for your information and record.
| /s/ Vikas Sabharwal | |
| Vikas Sabharwal | |
| Assistant Company Secretary | |
CC:- New York Stock Exchange Inc.(Stock Code :RDY)